PT-141 Purity Standards & COA Requirements
Navigating analytical quality control is essential when sourcing synthetic melanocortin agonists for preclinical evaluation. This reference guide outlines the necessary HPLC, mass spectrometry, and endotoxin testing protocols required to evaluate a valid PT-141 purity COA for laboratory research applications.
Quick answer
Navigating analytical quality control is essential when sourcing synthetic melanocortin agonists for preclinical evaluation. This reference guide outlines the necessary HPLC, mass spectrometry, and endotoxin testing protocols required to evaluate a valid PT-141 purity COA for laboratory research applications.
Key takeaways
- [PT-141](/research-peptides/pt-141), chemically designated as bremelanotide, is a synthetic cyclic heptapeptide analog derived from alpha-melanocyte-stimulating hormone (alpha-MSH).
- The molecular architecture of [PT-141](/research-peptides/pt-141) features the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a monoisotopic molecular weight of 1024.2 Da.
- High-Performance Liquid Chromatography (HPLC) serves as the primary quantitative method for determining peptide purity.
- While RP-HPLC quantifies chromatographic purity, Mass Spectrometry (MS) confirms molecular identity by measuring the exact mass-to-charge ratio (m/z) of the molecule.
Introduction to PT-141 Analytical Standards
PT-141, chemically designated as bremelanotide, is a synthetic cyclic heptapeptide analog derived from alpha-melanocyte-stimulating hormone (alpha-MSH). In preclinical models, the peptide functions as a non-selective melanocortin receptor agonist, exhibiting affinity across central and peripheral receptor subtypes. Researchers investigating neuroendocrine control, vascular signaling, and central melanocortin pathways require highly defined chemical lots to prevent confounding variable inputs in cellular and animal assays.
To ensure experimental reproducibility, investigators must verify batch consistency through comprehensive laboratory documentation. Obtaining a detailed PT-141 purity COA provides essential quantitative verification of compound identity, peptide content, impurity profiles, and biological contaminant levels before initiating in vitro or in vivo protocols.
Melanocortin Receptor Signaling and Structural Properties
The molecular architecture of PT-141 features the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a monoisotopic molecular weight of 1024.2 Da. Its lactam-bridge cyclization imparts structural stability relative to linear peptide predecessors. Preclinical investigations demonstrate that PT-141 preferentially binds to melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors within the central nervous system, while maintaining variable binding to MC1R and MC5R.
When evaluating melanocortin receptor agonists in central signaling research, subtle variations in primary sequence integrity or residual synthesis reagents can dramatically shift receptor binding kinetics. Consequently, evaluating primary sequence fidelity through rigorous chemical testing remains non-negotiable for structural and functional bioassays.
High-Performance Liquid Chromatography (HPLC) Analysis
High-Performance Liquid Chromatography (HPLC) serves as the primary quantitative method for determining peptide purity. Reverse-phase HPLC (RP-HPLC) separates PT-141 from truncated peptide sequences, deletion sequences, diastereomers, and synthesis side-products based on hydrophobic interactions with C18 stationary phases under acetonitrile gradient elution.
Analytical specifications for research-grade PT-141 mandate a minimum HPLC purity threshold of ≥98.0%, calculated via peak area integration at UV wavelengths of 214 nm and 280 nm. The primary chromatographic peak corresponding to PT-141 must demonstrate clean symmetry without shoulder peaks or co-eluting trace contaminants. Detailed peptide purity testing methods documented on a lot-specific basis allow researchers to confirm that minor peaks (representing synthesis impurities) do not exceed strict internal laboratory tolerances.
Mass Spectrometry Verification: Confirmation of Molecular Weight
While RP-HPLC quantifies chromatographic purity, Mass Spectrometry (MS) confirms molecular identity by measuring the exact mass-to-charge ratio (m/z) of the molecule. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) are standard analytical techniques used to confirm the molecular weight of PT-141.
A valid MS spectrum for PT-141 must exhibit a dominant single-charge or double-charge ion peak corresponding precisely to the theoretical mass of 1024.2 g/mol (such as [M+H]+ at 1025.2 m/z or [M+2H]2+ at 513.1 m/z). The absence of significant adduct peaks (e.g., sodium or potassium adducts) or mass-shifted fragment ions confirms structural integrity and complete deprotection during solid-phase peptide synthesis (SPPS).
Endotoxin Limits and Bioburden Assessment
Bacterial endotoxins, primarily lipopolysaccharides (LPS) originating from Gram-negative bacterial outer membranes, pose a significant risk in cell culture and animal research models. Presence of endotoxins can induce fever, inflammatory cytokine cascades, or cellular toxicity, confounding observations in preclinical signaling studies.
Quantitative Limulus Amebocyte Lysate (LAL) testing, performed according to USP <85> guidelines, measures bioburden levels in synthesized peptide lots. Standard research criteria require PT-141 lots to maintain endotoxin thresholds below 0.1 EU/mg (and ideally <0.05 EU/mg). Verifying low endotoxin status ensures that observed biological responses are attributable solely to melanocortin receptor activation rather than immune system activation triggered by bacterial contaminants.
Anatomy of an Authentic Certificate of Analysis
A comprehensive Certificate of Analysis provided by an independent, ISO 17025-accredited testing laboratory must include specific, verifiable data points. When reviewing a PT-141 purity COA, laboratory managers should verify the presence of the following critical sections:
1. Product Specifications: Chemical name, CAS number (189741-10-0), molecular formula (C50H68N14O10), and target molecular weight. 2. Lot Details: Unique batch/lot number, manufacturing date, and re-test date. 3. Appearance: Lyophilized powder clarity, color (typically off-white to white), and solubility characteristics. 4. HPLC Chromatogram: Visual peak integration chart displaying retention time, peak height, and percentage total area. 5. MS Data Spectrum: Mass spectral scan confirming target m/z. 6. Residual Analyses: Quantitative assessment of counter-ion content (acetate vs. TFA), residual moisture via Karl Fischer titration, and LAL endotoxin quantification.
Synthesis Impurities, Salt Forms, and Solvent Removal
During solid-phase peptide synthesis, trifluoroacetic acid (TFA) is routinely utilized during cleavage and side-chain deprotection steps. Unless subjected to extensive preparative purification and salt exchange, residual TFA counter-ions remain associated with basic amino acid residues (such as Arg, His, and Lys). Excess TFA can exhibit cellular toxicity in sensitive in vitro models.
High-purity research lots are routinely converted to acetate salt forms or meticulously washed to control TFA concentrations. Furthermore, volatile organic solvents used during synthesis—such as dimethylformamide (DMF), dichloromethane (DCM), and piperidine—must be removed below stringent parts-per-million (ppm) thresholds verified by Headspace Gas Chromatography (GC-MS).
Comparative Analysis of Melanocortin Class Compounds
When designing comparative signaling experiments, researchers frequently contrast PT-141 with related melanocortin receptor ligands. For instance, Melanotan II shares key structural elements with PT-141 but possesses different receptor subtype preferences and physiological pathways. Similarly, native endogenous ligands such as alpha-MSH display distinct metabolic degradation profiles in laboratory media.
Reviewing analytical documentation across these structurally related peptides allows investigators to normalize ligand concentration and purity profiles across experimental arms. Cross-referencing technical data in our comprehensive research library supports accurate experimental design when studying peptide-receptor dynamics.
PX1 Research Quality Control and Supply Logistics
PX1 Research adheres to rigorous manufacturing standards for all research compounds. Every lot of PT-141 is USA-synthesized within state-of-the-art GMP-compliant facilities and undergoes third-party analytical verification in ISO 17025 accredited laboratories prior to release.
To safeguard peptide stability during transit, PX1 utilizes specialized lyophilization parameters and protective packaging protocols. Orders for laboratory facilities ship same-day (Monday through Friday) directly from dual distribution hubs located in California and Arizona. Institutional facilities seeking bulk lots or dedicated batch reservations can coordinate directly through our wholesale service team.
Laboratory Reconstitution and Storage Protocol
To maintain the structural integrity verified on the COA, researchers must follow strict storage and reconstitution protocols upon receipt of lyophilized PT-141 vials:
- Lyophilized Storage: Store desiccated at -20°C for long-term stability. Avoid exposure to ambient light and moisture. - Reconstitution: Allow the vial to equilibrate to room temperature before opening. Reconstitute using sterile, laboratory-grade solvent such as bacteriostatic water or sterile 0.9% sodium chloride under a laminar flow hood. - Aliquoting: To avoid repeated freeze-thaw cycles that promote peptide degradation, aliquot the reconstituted solution into sterile polypropylene microcentrifuge tubes. - Working Solution Storage: Store liquid aliquots at 2°C to 8°C for short-term evaluation (up to 30 days) or freeze at -80°C for extended experimental timelines.
Frequently Asked Questions
What is the baseline purity standard required for PT-141 in research applications?
Preclinical in vitro and in vivo studies generally require a minimum HPLC purity threshold of ≥98.0%. Higher purity minimizes confounding cellular responses caused by peptide fragments or chemical impurities.
How is the molecular identity of PT-141 confirmed on a COA?
Molecular identity is verified using Mass Spectrometry (ESI-MS or MALDI-TOF), which measures the exact mass-to-charge ratio of the compound to ensure it matches the target mass of 1024.2 Da.
Why is endotoxin testing critical for PT-141 research lots?
Endotoxins (LPS) trigger inflammatory signaling cascades in immune and neuronal cell cultures. Verifying an endotoxin level below 0.1 EU/mg ensures that experimental observations reflect true receptor activation rather than an immune response.
What analytical method is used to determine residual solvent levels in peptide lots?
Headspace Gas Chromatography-Mass Spectrometry (GC-MS) is utilized to measure and ensure that residual organic solvents like DMF, DCM, and acetonitrile fall within safe analytical thresholds.
How does PT-141 differ structurally from Melanotan II?
While both are cyclic analogs derived from alpha-MSH, PT-141 features a carboxylic acid C-terminus (bremelanotide) rather than a C-terminal amide, altering its receptor binding profile and physical-chemical properties.
Where can institutional buyers access lot-specific third-party COAs from PX1 Research?
Lot-specific COAs generated by independent ISO 17025 laboratories are downloadable directly on product pages or provided upon request for institutional accounts.
What is the recommended reconstitution solvent for PT-141 research solutions?
Reconstitution is typically performed using sterile laboratory-grade bacteriostatic water (0.9% benzyl alcohol) or sterile physiological saline depending on the experimental design.
How are PX1 Research peptides shipped to maintain chemical stability?
Peptides are shipped in lyophilized powder form, which provides high temperature stability during transport. PX1 dispatches orders same-day Monday through Friday from facilities in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.